Jump to content

Diffusing capacity for carbon monoxide

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Headbomb (talk | contribs) at 03:40, 9 July 2016 (→Decrease: clean up, url redundant with pmc, add pmc, and/or remove accessdate if no url using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

DLCO or TLCO (diffusing capacity or transfer factor of the lung for carbon monoxide (CO),[1]) is the extent to which oxygen passes from the air sacs of the lungs into the blood. Commonly, it refers to the test used to determine this parameter. It was introduced in 1909.[2]

Mechanism of the DLCO Test

This test involves measuring the partial pressure difference between inspired and expired carbon monoxide. It relies on the strong affinity and large absorption capacity of erythrocytes for carbon monoxide and thus demonstrates gas uptake by the capillaries that are less dependent on cardiac output.[3] The measurement of DLCO is affected by atmospheric pressure and/or altitude and correction factors can be calculated using the method recommended by the American Thoracic Society.[4] Expected DLCO is also affected by the amount of hemoglobin, carboxyhemoglobin, age and sex. The correction for hemoglobin is based on the method of Cotes[5][6] as recommended by the American Thoracic Society. Online resources exist to facilitate these corrections for altitude, hemoglobin, and carboxyhemoglobin.

Factors affecting DLCO

Decrease

DLCO is decreased in any condition which affects the effective alveolar surface area:

  1. Hindrance in the alveolar wall. e.g. fibrosis, alveolitis, vasculitis
  2. Decrease of total lung area, e.g. Restrictive lung disease
  3. Chronic obstructive pulmonary disease (COPD) due to decreased surface area in the alveoli, as well as damage to the capillary bed[7]
  4. Uneven spread of air in lungs, e.g. emphysema
  5. Pulmonary embolism
  6. Cardiac insufficiency
  7. Pulmonary hypertension
  8. Bleomycin (upon administration of more than 200 units)
  9. Chronic heart failure[8]
  10. Anemia-due to decrease in blood volume
  11. Amiodarone high cumulative dose; more than 400 milligrams per day

However, many modern devices compensates for the hemoglobin value of the patient (taken by blood test), and excludes it as a factor in the DLCO interpretation.

Increase

Factors that can increase the DLCO include polycythaemia, asthma (can also have normal DLCO) and increased pulmonary blood volume as occurs in exercise. Other factors are left to right intracardiac shunting, and alveolar hemorrhage.[9]

Factors affected by DLCO

Decrease

A DLCO of less than 60% predicted portends a poor prognosis for lung cancer resection. FEV1 is of lesser prognostic value for lung resection survival.[10]

References

  1. ^ Macintyre N, Crapo RO, Viegi G, et al. (October 2005). "Standardisation of the single-breath determination of carbon monoxide uptake in the lung". Eur. Respir. J. 26 (4): 720–35. doi:10.1183/09031936.05.00034905. PMID 16204605.
  2. ^ Hughes J, Bates D (2003). "Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components". Respir Physiol Neurobiol. 138 (2–3): 115–42. doi:10.1016/j.resp.2003.08.004. PMID 14609505.
  3. ^ Sue DY, Oren A, Hansen JE & Wasserman K (1987). Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise. N. Engl. J. Med., 316(21):1301-1306.
  4. ^ American Thoracic society, Single Breath Carbon Monoxide Diffusing Capacity (transfer factor) Recommendations for a Standard Technique- 1995 Update, Am J Respir Crit Care Med. 152 pp 2185-2198 (1995).
  5. ^ J.E. Cotes 1993, Lung Function, 5th Edition., Blackwell Scientific Publications, London
  6. ^ J.E. Cotes, J.M. Dabbs, P.C. Elwood, A.M. Hall, A. McDonald, and M.J. Saunders. Iron-deficiency anaemia: its effects on transfer factor for the lung (diffusing capacity) and ventilation and cardiac frequency during submaximal exercise. Clin. Sci. 42:325-33 (1972).
  7. ^ Bailey, Kristina L. (1 July 2012). "The Importance of the Assessment of Pulmonary Function in COPD". The Medical clinics of North America. 96 (4): 745–752. doi:10.1016/j.mcna.2012.04.011. ISSN 0025-7125. PMC 3998207.
  8. ^ http://circ.ahajournals.org/content/91/11/2769.full
  9. ^ Ruppel, G. L. (2009). Manual of Pulmonary Function Testing. ISBN 978-0-323-05212-2
  10. ^ Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer (p n/a) Michael J. Liptay, Sanjib Basu, Michael C. Hoaglin, Neil Freedman, L. Penfield Faber, William H. Warren, Zane T. Hammoud, Anthony W. Kim. Journal of Surgical Oncology. Published Online: Oct 1 2009 8:20AM doi:10.1002/jso.21407
Retrieved from "https://en.wikipedia.org/w/index.php?title=Diffusing_capacity_for_carbon_monoxide&oldid=728998606"